Elidel-Study: Elidel in Patients With Atopic Dermatitis

Technische Universität Dresden

Status and phase: Completed; Phase 4

Conditions: Atopic Dermatitis

Treatments: Drug: Elidel-Creme

Study type: Interventional

Funder types: Other

Identifiers

NCT00180141

CASM981CDE16

Details and patient eligibility

About

Atopic dermatitis is a common disease. Emollients and Elidel have both shown to be effective to treat this disease. The research question is, whether the effective component (Elidel) is better than the emollient to improve the skin function.

Enrollment: 24 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Age > 18 years
• Atopic dermatitis on both lower arms at least 1% body surface area.
• Atopic Dermatitis Severity Index (ADSI)-Score >= 6
• Investigator Global Assessment (IGA)-Score >= 2

Exclusion criteria

• Systemic therapy with immunosuppressive drugs within the past 24 weeks
• Phototherapy against atopic dermatitis.
• Antibiotic therapy against atopic dermatitis.
• Allergy against Elidel.
• Pregnancy
• Nursing
• Skin cancer

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Double Blind